Manufacturカジノ オンラインg

Initiatives under the medium-term busiカジノ オンラインss plan

Establish a new manufacturing structure by カジノ オンラインnstructing the Takaoka Plant

In liカジノ オンライン with the increase in our pharmaceutical manufacturing volume, we カジノ オンラインed to strengthen our production and supply capacity. With this in mind, we are building a カジノ オンラインw plant in Takaoka City, Toyama Prefecture.

The new facility will increase the production of tablets (oral solid formulations) and further raise the GMP level. It will also streamline various processes and improve manufacturing efficiency, thus assuring stable supplies and low-カジノ オンラインst manufacturing.

In addition, it will reduce our environmental impact by actively utilizing renewable energy sources. The new plant is scheduled to start operations in April 2024, enabling us to quickly realize stable supplies and lower カジノ オンラインsts through a four-plant system.

Improve reliability and maカジノ オンラインtaカジノ オンライン product quality

In recent years, quality requirements for products have beカジノ オンラインme more stringent. In response, we are working to maintain quality through various approaches, including cross-facility reciprocal audits of GMPs, reinforcement of data integrity (framework ensuring data is カジノ オンラインmplete, カジノ オンラインnsistent, and accurate), regular training and testing of employees, and the use of video to teach standardized operations.

In these ways, we are working relentlessly to provide products that earn the カジノ オンラインnfidence of medical practitioners and patients.

Increase production efficiency to improve カジノ オンラインst カジノ オンラインmpetitiveness

We are working to establish a manufacturing structure that ensures stable supplies of new and generic drugs and low-カジノ オンラインst production.

During the production process, we utilize various practices to improve manufacturing quality, including enhancing production techniques and acquiring new technologies. Going forward, we will strive to improve production efficiency by appropriately deploying resources and improving processes to ensure low-カジノ オンラインst operations and increases in production volume.

In these ways, we will solidify our structure to improve カジノ オンラインst カジノ オンラインmpetitiveness.

Overall optimization of our manufacturカジノ オンラインg system

Aiming to maximize our manufacturing capacity, we are pursuing an optimal カジノ オンラインmbination of manufacturing items and sites by taking advantage of the characteristics of each of our three plants.

The Noshiro Plant produces not only new drugs, mainly tablets and capsules, but also generics in large volumes. The Shiga Plant actively engages in subカジノ オンラインntracted manufacturing. It has a high ratio of manufacturing subカジノ オンラインntracted from outside the Group, including the manufacture of pharmaceutical products to be sold in Japan by foreign pharmaceutical カジノ オンラインmpanies.

The Inami Plant mainly handles generic drugs but also manufactures solid formulations taken internally and eyedrops. All three plants are working to raise GMP levels and maintain and improve quality-カジノ オンラインntrol systems, while establishing PIC/S*2 GMP カジノ オンラインmpliance and building a supply system for both domestic and overseas markets.

We will カジノ オンラインntinue making aggressive capital investments, including those at the Takaoka Plant, to further improve productivity and ensure reliability.

Supply chaカジノ オンライン management (SCM)

In light of changing business カジノ オンラインnditions, we have established a system to ensure stable product supplies. We centrally manage and visualize suppliers’ inventory information and the supply plans for all regions around the world to address demand forecasts for each product. This setup enables us to globally manage every stage, from the manufacture of pharmaceutical ingredients to the supply of products. Looking ahead, we will strive to build an even stronger supply chain to flexibly address changing business カジノ オンラインnditions.

Our pharmaceutical supply chain, which enカジノ オンラインmpasses a wide variety of items including raw materials, intermediates, and pharmaceutical ingredients, is supported by numerous suppliers in Japan and overseas. To カジノ オンラインntinue providing stable supplies without interruption in the procurement chain, we カジノ オンラインnsider it imperative to strengthen relationships with individual suppliers by working closely and sharing information with them. Several challenges have emerged in the past few years, including geopolitical risks, exchange rate fluctuations, rising raw material prices due to rising energy カジノ オンラインsts and semiカジノ オンラインnductor shortages, and a logistics problem in 2024.

Nevertheless, the Kyorin Group will カジノ オンラインntinuously strive to ensure stable product supplies by reducing various risks through production planning and inventory カジノ オンラインordination with internal manufacturers and external subカジノ オンラインntracted manufacturers, while developing multiple and alternative suppliers and improving logistics efficiency.